Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other Working Capital Changes (2024 - 2025)

Historic Other Working Capital Changes for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $33000.0.

  • Kairos Pharma's Other Working Capital Changes rose 175000.0% to $33000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $71000.0, marking a year-over-year change of. This contributed to the annual value of $30000.0 for FY2024, which is 27500.0% up from last year.
  • Per Kairos Pharma's latest filing, its Other Working Capital Changes stood at $33000.0 for Q2 2025, which was up 175000.0% from $17000.0 recorded in Q1 2025.
  • Over the past 5 years, Kairos Pharma's Other Working Capital Changes peaked at $33000.0 during Q2 2025, and registered a low of -$7000.0 during Q3 2024.